Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
RevoluGen
RevoluGen
Activities:
Analysis
X
LinkedIn
Trending Articles
Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
You need to be a subscriber to read this article.
Click here
to find out more.
How CDMOs can set a new gold standard when it comes to going green
Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...
Newcells Biotech raises additional funding from investors
Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
Mastering modified-release performance: excipient considerations
Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic...
ACG expands global footprint with new capsule manufacturing facility in Thailand
New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Manufacturing
Automated HMW-DNA extraction validated on Tecan robot
Further optimisation of the multi-well filter plates is ongoing in RevoluGen’s R&D laboratories with commercial launch of the automated Fire Monkey HMW-DNA extraction kit anticipated in the coming months
Subscribe now